<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ischemic brain is particularly susceptible to free radicals mediated secondary neuronal damage, especially <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunctions </plain></SENT>
<SENT sid="1" pm="."><plain>Chinese Herbal Medicine with <z:chebi fb="11" ids="22586">antioxidant</z:chebi> properties is believed to have potential therapeutic effect </plain></SENT>
<SENT sid="2" pm="."><plain>Leonurine, an <z:chebi fb="13" ids="22315">alkaloid</z:chebi> present in Herba Leonuri (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>), has shown biological effects such as <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, anti-<z:mpath ids='MPATH_3'>apoptosis</z:mpath> and protection against <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, neuroprotective effects of leonurine against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion-induced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunctions in cortex were evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>We used transient rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The rats were treated with their respective treatments for 1 week prior to the MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>We found that leonurine significantly improved neurological outcome and reduced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion (I/R)-induced <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> 24 h after MCAO </plain></SENT>
<SENT sid="7" pm="."><plain>Leonurine decreased reactive oxygen species (ROS) level in mitochondria isolated from ischemic cortex, which was increased by MCAO </plain></SENT>
<SENT sid="8" pm="."><plain>Terminal deoxyuridine <z:chebi fb="0" ids="15266,18036">triphosphate</z:chebi> (<z:chebi fb="0" ids="17625">dUTP</z:chebi>) Nick-End Labeling (TUNEL) staining showed anti-apoptotic effect of leonurine on ischemic cortex </plain></SENT>
<SENT sid="9" pm="."><plain>Western blot analysis showed a marked decrease in the expression of Bax and an increase of Bcl-2 as a result of leonurine treatment </plain></SENT>
<SENT sid="10" pm="."><plain>The attenuation of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane swelling, restore of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential and content of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> (<z:chebi fb="0" ids="16040">Cyt</z:chebi>-C) in mitochondria isolated from ischemic cortex could also be observed in leonurine treated group </plain></SENT>
<SENT sid="11" pm="."><plain>The findings of this study suggest that leonurine has promising therapeutic effect for <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> treatment through <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and anti-apoptotic mechanisms </plain></SENT>
</text></document>